Isopathic therapy for aminoglycoside sensorineural hearing loss and deafness (preliminary results)
AUTHORS : Abakarov1 M.G. | Belousov1 Yu.B. | Magomedov MM. | Gotovsky2 M.Yu.
RELEVANT UNIVERSITIES : 1Russian State Medical University, Moscow, 2Centre
“IMEDIS”, Moscow
YEAR : 2007
The aim of this controlled clinical trial is to evaluatethe effectiveness of isopathic therapy for ototoxic sensorineural hearing loss with potentiated aminoglycosides. Control baseline before starting isopathic therapy. A number of criteria have been selected to assess the effectiveness: criterion A – the disappearance of subjective ear noise; Criterion B – expanding the range of perceived frequencies (according to tone threshold audiometry (TPA) data by at least 1 range for bone conduction and criterion C – reducing the perception thresholds at a frequency of 1 kHz or 2 kHz by at least 20 dB.
